GR3023510T3 - Recombinant dna method and vectors for use therein - Google Patents

Recombinant dna method and vectors for use therein

Info

Publication number
GR3023510T3
GR3023510T3 GR970400941T GR970400941T GR3023510T3 GR 3023510 T3 GR3023510 T3 GR 3023510T3 GR 970400941 T GR970400941 T GR 970400941T GR 970400941 T GR970400941 T GR 970400941T GR 3023510 T3 GR3023510 T3 GR 3023510T3
Authority
GR
Greece
Prior art keywords
gene
glutamine
vectors
recombinant dna
dna method
Prior art date
Application number
GR970400941T
Other languages
English (en)
Inventor
Christopher Robert Bebbington
Geoffrey Thomas Yarranton
Original Assignee
Alusuisse Holdings Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alusuisse Holdings Ag filed Critical Alusuisse Holdings Ag
Publication of GR3023510T3 publication Critical patent/GR3023510T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GR970400941T 1989-10-25 1997-05-22 Recombinant dna method and vectors for use therein GR3023510T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898924021A GB8924021D0 (en) 1989-10-25 1989-10-25 Recombinant dna method and vectors for the use therein
PCT/GB1990/001640 WO1991006657A1 (en) 1989-10-25 1990-10-25 Recombinant dna method and vectors for use therein

Publications (1)

Publication Number Publication Date
GR3023510T3 true GR3023510T3 (en) 1997-08-29

Family

ID=10665141

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400941T GR3023510T3 (en) 1989-10-25 1997-05-22 Recombinant dna method and vectors for use therein

Country Status (11)

Country Link
EP (1) EP0491875B1 (el)
JP (1) JP3073009B2 (el)
AT (1) ATE153383T1 (el)
AU (1) AU6629990A (el)
CA (1) CA2071543C (el)
DE (1) DE69030768T2 (el)
DK (1) DK0491875T3 (el)
ES (1) ES2104616T3 (el)
GB (1) GB8924021D0 (el)
GR (1) GR3023510T3 (el)
WO (1) WO1991006657A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597886B2 (en) 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
CA2257357C (en) 1996-06-07 2010-04-13 Neorx Corporation Humanized antibodies with modified glycosylation
EP2213743A1 (en) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albumin fusion proteins
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
EP2431054A3 (en) 2000-06-15 2013-03-06 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
JP2004536579A (ja) 2001-04-13 2004-12-09 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 血管内皮増殖因子2
US7064189B2 (en) 2001-05-25 2006-06-20 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2003066824A2 (en) 2002-02-07 2003-08-14 Aventis Behring Gmbh Albumin-fused kunitz domain peptides
HUE027902T2 (en) 2004-02-09 2016-11-28 Human Genome Sciences Inc Corp Service Company Albumin fusion proteins
US7973139B2 (en) 2004-03-26 2011-07-05 Human Genome Sciences, Inc. Antibodies against nogo receptor
US9505823B2 (en) 2006-08-07 2016-11-29 TEV A Biopharmaceuticals USA, Inc. Albumin-insulin fusion proteins
US9540426B2 (en) 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
EP2325322A1 (en) 2009-11-23 2011-05-25 4-Antibody AG Retroviral vector particles and methods for their generation and use
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
AU2012222833B2 (en) 2011-03-03 2017-03-16 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs
US20140356863A1 (en) 2011-11-21 2014-12-04 Bristol-Myers Squibb Company Methods for determining the susceptibility of a virus to an attachment inhibitor
US9657310B2 (en) 2012-04-27 2017-05-23 Jcr Pharmaceuticals Co., Ltd. Expression vector
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
WO2014012082A2 (en) 2012-07-13 2014-01-16 Zymeworks Inc. Multivalent heteromultimer scaffold design an constructs
JP2015531244A (ja) 2012-10-15 2015-11-02 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company タンパク質を製造するための哺乳動物細胞培養方法
WO2014182970A1 (en) 2013-05-08 2014-11-13 Zymeworks Inc. Bispecific her2 and her3 antigen binding constructs
CA2874083C (en) 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
WO2016130734A1 (en) 2015-02-11 2016-08-18 Bristol-Myers Squibb Company Use of phenolic antioxidants in cell culture for the production of proteins
WO2017083224A1 (en) 2015-11-09 2017-05-18 Bristol-Myers Squibb Company Methods to manipulate quality attributes of polypeptides produced in cho cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601597D0 (en) * 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
EP0319206A3 (en) * 1987-11-30 1990-04-18 Berlex Laboratories, Inc. Gene amplification
GB8809129D0 (en) * 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells

Also Published As

Publication number Publication date
GB8924021D0 (en) 1989-12-13
CA2071543C (en) 2005-02-22
ATE153383T1 (de) 1997-06-15
ES2104616T3 (es) 1997-10-16
WO1991006657A1 (en) 1991-05-16
AU6629990A (en) 1991-05-31
EP0491875B1 (en) 1997-05-21
CA2071543A1 (en) 1991-04-26
EP0491875A1 (en) 1992-07-01
JPH05504050A (ja) 1993-07-01
JP3073009B2 (ja) 2000-08-07
DE69030768D1 (de) 1997-06-26
DK0491875T3 (da) 1997-06-16
DE69030768T2 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
GR3023510T3 (en) Recombinant dna method and vectors for use therein
NO964445L (no) DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA
AU553885B2 (en) Expression of exogenous polypeptides in yeast
DK639689D0 (da) Indfoering af dna i celler
GB8809129D0 (en) Recombinant dna methods vectors and host cells
ATA392082A (de) Verfahren und vorrichtung zum handhaben von gegenstaenden mittels kontinuierlich bewegter arbeitsmittel
EP0074808A3 (en) Recombinant method and materials
EP0049619A3 (en) Method for stabilizing and selecting host cells containing recombinant dna
CA2140550A1 (en) Cloning and expression of a human .alpha.(1,3)fucosyltransferase, fuct-vi
GB8810400D0 (en) Analysing polynucleotide sequences
DK0877819T3 (da) Onkogene mutanter af genet TSG101
Piper et al. Nonsense suppressors of Saccharomyces cerevisiae can be generated by mutation of the tyrosine tRNA anticodon
JP2008086326A (ja) ゲノム性要素を使用する遺伝子の操作および発現
AU7177896A (en) Multidrug resistance gene
DE3478699D1 (en) Method for producing interferons
EP0161935A3 (en) Method, vectors and transformants for high expression of heterologous polypeptides in yeast
WO1995023855A3 (en) Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
ES2123569T3 (es) Regulacion de genes en celulas de mamifero dependiente de ecdiesteroides.
EP0077689A3 (en) Method of gene manipulation using an eukaryotic cell as the host
DE3069489D1 (en) Expandable electrode suitable for use in an electrolytic cell of the diaphragm or membrane type, and said electrolytic cell
AU5945386A (en) Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
MX9600860A (es) Metodo para detectar polimorfismo de gen p4501a2 de citocromo humano.
SE8404637L (sv) Plasmidvektorer med hogt kopeieringstal, framstellning och anvendning derav
ES8802251A1 (es) Un procedimiento para preparar un microorganismo hospedante transformado del genero sacharomyces.
AU6077599A (en) Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)